RxNorm Semantic Concepts Index - 412
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "412".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 412000 | diethylpropion 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412001 | zinc gluconate 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412002 | FESO4 272 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412002 | FESO4 272 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412003 | FESO4 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412003 | FESO4 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412004 | FESO4 192 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412004 | FESO4 192 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412005 | FESO4 304 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412005 | FESO4 304 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412007 | ferrous gluconate 370 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412008 | ferrous gluconate 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412009 | ferrous fumarate 480 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412010 | ferrous fumarate 350 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412011 | ferrous fumarate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412015 | Cyanocobalamin 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412015 | Cyanocobalamin 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412018 | biotin 2500 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 412018 | biotin 2500 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 412018 | biotin 2500 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 412019 | biotin 0.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412020 | rutin 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412021 | rutin 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412023 | fenofibrate 67 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412029 | ouabain 3 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412031 | NaHCO3 500 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412031 | NaHCO3 500 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412040 | dimethindene 4 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412041 | acemetacin 90 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412042 | furosemide 50 MG / triamterene 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412043 | furosemide 25 MG / triamterene 15 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412044 | sulpiride 100 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412046 | etofibrate 500 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412047 | nilvadipine 8 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412048 | nilvadipine 16 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412050 | betahistine 12 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412051 | ambroxol 30 MG / theophylline 350 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412052 | Ferrous fumarate 60 MG / folate 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412052 | Ferrous fumarate 60 MG / folate 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412053 | Ferrous fumarate 290 MG / folate 0.35 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412053 | Ferrous fumarate 290 MG / folate 0.35 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412054 | vitamin C 50 MG / ferrous sulfate 165 MG (iron 54.45 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412054 | vitamin C 50 MG / ferrous sulfate 165 MG (iron 54.45 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412054 | vitamin C 50 MG / ferrous sulfate 165 MG (iron 54.45 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412054 | vitamin C 50 MG / ferrous sulfate 165 MG (iron 54.45 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412055 | vitamin C 50 MG / ferrous fumarate 16.4 MG (iron 5.4 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412055 | vitamin C 50 MG / ferrous fumarate 16.4 MG (iron 5.4 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412055 | vitamin C 50 MG / ferrous fumarate 16.4 MG (iron 5.4 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412055 | vitamin C 50 MG / ferrous fumarate 16.4 MG (iron 5.4 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412065 | vitamin E 268 MG (400 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412065 | vitamin E 268 MG (400 UNT) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412069 | vitamin E 402 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412071 | vitamin E 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412072 | eucalyptol 100 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412076 | spike lavender oil 150 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412077 | simethicone 25 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412077 | simethicone 25 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412078 | pancreatin 309 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412079 | pancreatin 154 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41208 | halobetasol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 41208 | halobetasol | Designated preferred name (PT) | YES | |
| RxCUI: 41208 | halobetasol | Full form of descriptor (FN) | YES | |
| RxCUI: 41208 | halobetasol | Designated preferred name (PT) | YES | |
| RxCUI: 41208 | halobetasol | Full form of descriptor (FN) | YES | |
| RxCUI: 412080 | pancreatin 556 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412081 | pancreatin 150 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412082 | pancreatin 463 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412083 | pancreatin 300 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412085 | urapidil 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412086 | urapidil 90 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412087 | urapidil 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412090 | vinburnine 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412091 | codeine 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412093 | beta-escin 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412103 | sodium fluoride 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412104 | betaine 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412104 | betaine 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412105 | betaine 520 MG / pepsin A 104 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412106 | betaine 648 MG / pepsin A 130 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412107 | betaine 460 MG / pepsin A 230 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412108 | aluminum hydroxide 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412109 | magnesium carbonate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412110 | betaine 324 MG / pepsin A 65 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412111 | simethicone 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 412111 | simethicone 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 412113 | vitamin E 180 MG (400 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 412114 | activated charcoal 225 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412115 | activated charcoal 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 412115 | activated charcoal 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 412116 | activated charcoal 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412117 | activated charcoal 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412118 | activated charcoal 162 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412119 | edetic acid 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412120 | penicillamine 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412120 | penicillamine 300 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412121 | allopurinol 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412127 | hyaluronic acid 1.8 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412128 | hyaluronic acid 4 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412129 | hyaluronic acid 3 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412143 | lactase 3000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412144 | lactase 9000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412145 | lactase 3400 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412148 | sennosides, USP 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412150 | sennosides, USP 170 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412151 | sennosides, USP 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412153 | cascara sagrada 325 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412156 | vitamin B6 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412157 | vitamin B6 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412158 | 12 HR indomethacin 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412159 | 12 HR ketoprofen 160 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412160 | 24 HR ketoprofen 320 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412162 | 24 HR ASA 75 MG / Isosorbide Mononitrate 60 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412162 | 24 HR ASA 75 MG / Isosorbide Mononitrate 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412163 | 24 HR verapamil 160 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412164 | 24 HR verapamil 80 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412165 | 24 HR dihydroergocristine 6 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412168 | mineral oil 2250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412169 | mineral oil 2200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412170 | mineral oil 950 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412171 | acetohydroxamic acid 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412172 | acetohydroxamic acid 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412173 | pancreatin 325 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412174 | ursodiol 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 412174 | ursodiol 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 412176 | niacinamide 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412177 | leucovorin 19 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412178 | leucovorin 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412179 | leucovorin 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412180 | leucovorin 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412181 | 24 HR nilvadipine 8 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412182 | 24 HR nilvadipine 16 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41219 | Hb 143(H21), His-arg | British preferred term (PTGB) | NO | |
| RxCUI: 41219 | Hb 143(H21), His-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41219 | Hb 143(H21), His-arg | Designated preferred name (PT) | NO | |
| RxCUI: 41219 | Hb 143(H21), His-arg | Full form of descriptor (FN) | NO | |
| RxCUI: 412191 | FESO4 80 MG / folate 0.3 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412191 | FESO4 80 MG / folate 0.3 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412192 | LORazepam 2 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412192 | LORazepam 2 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412192 | LORazepam 2 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412194 | bromazepam 6 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412195 | bromazepam 3 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412196 | xanthinol niacinate 500 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412198 | roxatidine 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412199 | roxatidine 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41220 | Hemoglobin C-Ziguinchor | British preferred term (PTGB) | NO | |
| RxCUI: 41220 | Hemoglobin C-Ziguinchor | Designated preferred name (PT) | NO | |
| RxCUI: 41220 | Hemoglobin C-Ziguinchor | Full form of descriptor (FN) | NO | |
| RxCUI: 412200 | mepirodipine 10 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412202 | mepirodipine 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41222 | Hb 120(GH3), Lys-ile | British preferred term (PTGB) | NO | |
| RxCUI: 41222 | Hb 120(GH3), Lys-ile | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41222 | Hb 120(GH3), Lys-ile | Designated preferred name (PT) | NO | |
| RxCUI: 41222 | Hb 120(GH3), Lys-ile | Full form of descriptor (FN) | NO | |
| RxCUI: 412222 | sodium phosphate, dibasic 488 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412223 | magnesium citrate 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412224 | castor oil 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412225 | castor oil 2000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412226 | castor oil 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412227 | calcifediol 0.125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412228 | dihydrotachysterol 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41223 | Hemoglobin Lepore-Baltimore | British preferred term (PTGB) | NO | |
| RxCUI: 41223 | Hemoglobin Lepore-Baltimore | Designated preferred name (PT) | NO | |
| RxCUI: 41223 | Hemoglobin Lepore-Baltimore | Full form of descriptor (FN) | NO | |
| RxCUI: 412231 | vitamin C 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412231 | vitamin C 120 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412231 | vitamin C 120 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412232 | vitamin C 180 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412232 | vitamin C 180 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412232 | vitamin C 180 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412233 | vitamin C 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412233 | vitamin C 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412233 | vitamin C 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412238 | norfenefrine 25 MG / pholedrine 25 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41224 | Hb 68(E12), Leu-pro | British preferred term (PTGB) | NO | |
| RxCUI: 41224 | Hb 68(E12), Leu-pro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41224 | Hb 68(E12), Leu-pro | Designated preferred name (PT) | NO | |
| RxCUI: 41224 | Hb 68(E12), Leu-pro | Full form of descriptor (FN) | NO | |
| RxCUI: 412240 | benzocaine 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412241 | PHENobarbital 100 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412241 | PHENobarbital 100 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412246 | cascara sagrada 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412247 | cascara sagrada 320 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412248 | cascara sagrada 390 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41225 | Hb Sealy | British preferred term (PTGB) | NO | |
| RxCUI: 41225 | Hb Sealy | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41225 | Hb Sealy | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41225 | Hb Sealy | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41225 | Hb Sealy | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41225 | Hb Sealy | Designated preferred name (PT) | NO | |
| RxCUI: 41225 | Hb Sealy | Full form of descriptor (FN) | NO | |
| RxCUI: 412250 | simethicone 160 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412250 | simethicone 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412251 | simethicone 45 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412252 | sodium fluoride 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412254 | tormentil 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41226 | Hb 14(A11), Leu-arg | British preferred term (PTGB) | NO | |
| RxCUI: 41226 | Hb 14(A11), Leu-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41226 | Hb 14(A11), Leu-arg | Designated preferred name (PT) | NO | |
| RxCUI: 41226 | Hb 14(A11), Leu-arg | Full form of descriptor (FN) | NO | |
| RxCUI: 412261 | beta carotene 6.6 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412262 | beta carotene 3 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412263 | beta carotene 3000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412264 | beta carotene 40000 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41227 | Hb 109(G16), Leu-arg | British preferred term (PTGB) | NO | |
| RxCUI: 41227 | Hb 109(G16), Leu-arg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41227 | Hb 109(G16), Leu-arg | Designated preferred name (PT) | NO | |
| RxCUI: 41227 | Hb 109(G16), Leu-arg | Full form of descriptor (FN) | NO | |
| RxCUI: 412273 | 12 HR disopyramide 125 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412278 | guaiFENesin 400 MG / phenylephrine HCl 30 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412278 | guaiFENesin 400 MG / phenylephrine HCl 30 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412278 | guaiFENesin 400 MG / phenylephrine HCl 30 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412278 | guaiFENesin 400 MG / phenylephrine HCl 30 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412278 | guaiFENesin 400 MG / phenylephrine HCl 30 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 412279 | oxazepam 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412281 | PHENobarbital 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412281 | PHENobarbital 60 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412283 | ZnSO4 22.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412283 | ZnSO4 22.5 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41229 | Hb 21(B3), Asp-tyr | British preferred term (PTGB) | NO | |
| RxCUI: 41229 | Hb 21(B3), Asp-tyr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41229 | Hb 21(B3), Asp-tyr | Designated preferred name (PT) | NO | |
| RxCUI: 41229 | Hb 21(B3), Asp-tyr | Full form of descriptor (FN) | NO | |
| RxCUI: 412301 | deferiprone 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412307 | guaifenesin 400 MG / pseudoephedrine HCl 90 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412307 | guaifenesin 400 MG / pseudoephedrine HCl 90 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412307 | guaifenesin 400 MG / pseudoephedrine HCl 90 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412307 | guaifenesin 400 MG / pseudoephedrine HCl 90 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412308 | guaifenesin 375 MG / phenylephrine HCl 20 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412308 | guaifenesin 375 MG / phenylephrine HCl 20 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412308 | guaifenesin 375 MG / phenylephrine HCl 20 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412308 | guaifenesin 375 MG / phenylephrine HCl 20 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412309 | 12 HR furosemide 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412310 | 12 HR ergoloid mesylates, USP 2.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412311 | FESO4 30 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412311 | FESO4 30 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412312 | FESO4 168 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412312 | FESO4 168 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412313 | ferrous fumarate 304 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412317 | vitamin K3 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412319 | thioctic acid 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412339 | oxyfedrine 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412340 | pridinol 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412345 | vitamin K1 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412353 | cholecalciferol 50000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41236 | Hepoxilin-epoxide hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 41236 | Hepoxilin-epoxide hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 4124 | Ethinylestradiol-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 4124 | Ethinylestradiol-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 4124 | Ethinylestradiol-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 4124 | Ethinylestradiol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 4124 | Ethinylestradiol-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 4124 | Ethinylestradiol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 4124 | Ethinylestradiol-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 412412 | dipyrone 500 MG/ML / trospium 0.04 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412417 | talinolol 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412418 | tilidine 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412419 | metylperon 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412421 | Magnesium Aspartate 72 MG/ML / Pot Aspartate 171 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412421 | Magnesium Aspartate 72 MG/ML / Pot Aspartate 171 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412421 | Magnesium Aspartate 72 MG/ML / Pot Aspartate 171 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412422 | Magnesium Aspartate 35 MG/ML / Pot Aspartate 35 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412422 | Magnesium Aspartate 35 MG/ML / Pot Aspartate 35 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412422 | Magnesium Aspartate 35 MG/ML / Pot Aspartate 35 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412425 | lidocaine 20 MG/ML / norepinephrine 0.02 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412426 | lidocaine 30 MG/ML / norepinephrine 0.04 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412452 | insulin, regular, pork 10 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412453 | insulin, regular, human 5 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412454 | magnesium gluconate 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412457 | titanium dioxide 0.1 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412474 | hemin 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412475 | pentoxifylline 16.7 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412481 | dipyrone 1.25 MG/ML / propinox 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412485 | propinox 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412486 | propinox 0.6 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412495 | lidocaine 30 MG/ML / norepinephrine 0.08 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412497 | piroxicam 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412499 | magnesium gluconate 0.052 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | British preferred term (PTGB) | YES | |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | British preferred term (PTGB) | YES | |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Designated preferred name (PT) | YES | |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Full form of descriptor (FN) | YES | |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Designated preferred name (PT) | YES | |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 4125 | Iodized ethyl esters of poppy seed fatty acids | Full form of descriptor (FN) | YES | |
| RxCUI: 412500 | magnesium chloride 36.7 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412501 | magnesium chloride 96 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412506 | ferrous gluconate 12.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412510 | magnesium sulfate 1.2 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412511 | magnesium sulfate 0.96 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412512 | magnesium sulfate 320 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412515 | K+ Chloride 2.68 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412515 | K+ Chloride 2.68 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412515 | K+ Chloride 2.68 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412520 | thymus gland-calf 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412550 | methimazole 500 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412550 | methimazole 500 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412551 | methimazole 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412551 | methimazole 40 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412562 | mechlorethamine 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412564 | tubocurarine 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412573 | piroxicam 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412580 | thymus gland-calf 11 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412586 | mannitol 500 MG/ML / mecobalamin 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 4126 | Amifostine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 4126 | Amifostine | Designated preferred name (PT) | YES | |
| RxCUI: 4126 | Amifostine | Full form of descriptor (FN) | YES | |
| RxCUI: 4126 | Amifostine | Designated preferred name (PT) | YES | |
| RxCUI: 4126 | Amifostine | Full form of descriptor (FN) | YES | |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | Designated preferred name (PT) | NO | |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41261 | HLA - Human leukocyte antigen B21 | Full form of descriptor (FN) | NO | |
| RxCUI: 41262 | Human leucocyte antigen B38 | Designated preferred name (PT) | NO | |
| RxCUI: 41262 | Human leucocyte antigen B38 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41262 | Human leucocyte antigen B38 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41262 | Human leucocyte antigen B38 | Full form of descriptor (FN) | NO | |
| RxCUI: 412624 | capsaicin 0.0025 MG/MG Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41264 | Human leukocyte antigen DQw6 | Designated preferred name (PT) | NO | |
| RxCUI: 41264 | Human leukocyte antigen DQw6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41264 | Human leukocyte antigen DQw6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41264 | Human leukocyte antigen DQw6 | Full form of descriptor (FN) | NO | |
| RxCUI: 412642 | prednisolone 8 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412642 | prednisolone 8 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412650 | tasonermin 0.2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412660 | flupirtine 33.3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412662 | gonadorelin 0.025 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412669 | pangamic acid 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412674 | hepatitis B immune globulin 200 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 412675 | hepatitis B immune globulin 50 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 4127 | Ethioniamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 4127 | Ethioniamide | Designated preferred name (PT) | YES | |
| RxCUI: 4127 | Ethioniamide | Full form of descriptor (FN) | YES | |
| RxCUI: 4127 | Ethioniamide | Designated preferred name (PT) | YES | |
| RxCUI: 4127 | Ethioniamide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 4127 | Ethioniamide | Full form of descriptor (FN) | YES | |
| RxCUI: 412707 | choline 187 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412715 | pheniramine 22.8 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412715 | pheniramine 22.8 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| RxCUI: 412715 | pheniramine 22.8 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 412716 | ketorolac 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412718 | cloZAPine 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412718 | cloZAPine 25 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 412719 | domperidone 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412720 | domperidone 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412723 | Hyoscine butylbromide 20 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412723 | Hyoscine butylbromide 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 412723 | Hyoscine butylbromide 20 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412723 | Hyoscine butylbromide 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 412746 | permethrin 10 MG/ML Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412753 | chlorhexidine 2 MG/ML Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41276 | Hycolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 412760 | nicotinyl alcohol 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412762 | papaverine 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412763 | papaverine 60 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412764 | TNG 1.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412764 | TNG 1.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412764 | TNG 1.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412766 | RNA 1.2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41277 | hydrocortisone aceponate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 41277 | hydrocortisone aceponate | Designated preferred name (PT) | NO | |
| RxCUI: 41277 | hydrocortisone aceponate | Full form of descriptor (FN) | NO | |
| RxCUI: 412771 | hydrochloric acid 72.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412774 | ceruletide diethylamine 0.005 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412775 | ceruletide diethylamine 0.03 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412788 | coal tar 0.02 MG/MG Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412813 | saralasin 0.6 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412817 | aminophylline 120 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41283 | Hygromycin-B kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 41283 | Hygromycin-B kinase | Designated preferred name (PT) | NO | |
| RxCUI: 41283 | Hygromycin-B kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 41283 | Hygromycin-B kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 412886 | theophylline 41.6 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412887 | theophylline 40 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412888 | ouabain 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412889 | ouabain 0.125 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 41289 | ibutilide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 41289 | ibutilide | Designated preferred name (PT) | YES | |
| RxCUI: 41289 | ibutilide | Full form of descriptor (FN) | YES | |
| RxCUI: 41289 | ibutilide | Designated preferred name (PT) | YES | |
| RxCUI: 41289 | ibutilide | Full form of descriptor (FN) | YES | |
| RxCUI: 412895 | digitoxin 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412897 | Rho(D) immune globulin 0.2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412899 | varicella-zoster immune globulin 25 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 4129 | Ethisterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 4129 | Ethisterone | Designated preferred name (PT) | NO | |
| RxCUI: 4129 | Ethisterone | Full form of descriptor (FN) | NO | |
| RxCUI: 4129 | Ethisterone | Designated preferred name (PT) | NO | |
| RxCUI: 4129 | Ethisterone | Full form of descriptor (FN) | NO | |
| RxCUI: 412902 | phenol 60 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412908 | tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412916 | greater celandine 10 MG/ML / silymarin 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412931 | mecobalamin 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412978 | insulin isophane, human 16 UNT/ML / insulin, regular, human 24 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 412992 | tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |